Insider · CIK 0001437903
David M Guthrie
Files at RPAY (Repay Holdings Corp). First filing -, latest -.
David M Guthrie files SEC Form 4 as officer at RPAY (Repay Holdings Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David M Guthrie has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 31, 2026 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +1,000 | $2.85 | $2,850 | 458,185 | Jun 2, 2026 |
| May 31, 2026 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -79 | $3.88 | $307 | 458,106 | Jun 2, 2026 |
| Mar 19, 2026 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -6,627 | $2.65 | $18k | 457,185 | Mar 23, 2026 |
| Mar 11, 2026 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +207,570 | $0.00 | $0 | 463,812 | Mar 13, 2026 |
| Mar 5, 2026 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -7,641 | $3.03 | $23k | 256,242 | Mar 9, 2026 |
| Feb 19, 2026 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -6,451 | $3.14 | $20k | 265,993 | Feb 23, 2026 |
| Feb 23, 2026 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -2,110 | $3.06 | $6,457 | 263,883 | Feb 23, 2026 |
| Nov 30, 2025 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +1,000 | $2.82 | $2,820 | 272,489 | Dec 2, 2025 |
| Nov 30, 2025 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -45 | $3.32 | $149 | 272,444 | Dec 2, 2025 |
| May 31, 2025 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +1,000 | $4.09 | $4,090 | 271,534 | Jun 3, 2025 |
| May 31, 2025 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -45 | $4.81 | $216 | 271,489 | Jun 3, 2025 |
| Mar 19, 2025 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -6,671 | $5.88 | $39k | 270,534 | Mar 21, 2025 |
| Mar 5, 2025 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +94,320 | $0.00 | $0 | 277,205 | Mar 7, 2025 |
| Feb 23, 2025 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -1,801 | $7.20 | $13k | 182,885 | Feb 25, 2025 |
| Feb 19, 2025 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -5,671 | $7.40 | $42k | 184,686 | Feb 21, 2025 |
| Feb 12, 2025 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +13,827 | $0.00 | $0 | 195,202 | Feb 14, 2025 |
| Feb 12, 2025 | RPAY Repay Holdings Corp | FTax withholding Class A Common Stock | -4,845 | $7.19 | $35k | 190,357 | Feb 14, 2025 |
| Nov 30, 2024 | RPAY Repay Holdings Corp | AGrant or award Class A Common Stock | +596 | $6.87 | $4,095 | 181,402 | Dec 3, 2024 |
| Nov 30, 2024 | RPAY Repay Holdings Corp | DDisposition to issuer Class A Common Stock | -27 | $8.08 | $218 | 181,375 | Dec 3, 2024 |
Questions about David M Guthrie
Answered from the filings on this page, as of the latest one.
Is David M Guthrie buying or selling?
David M Guthrie has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David M Guthrie's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David M Guthrie has 0.
Where does David M Guthrie file Form 4?
David M Guthrie has filed Form 4 at RPAY (Repay Holdings Corp) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.